Eikon raised $350.7M in a Series D funding round led by existing investors to advance its cancer trials.
Feb 28, 2025•10 months ago
Amount Raised
$351 Million
Round Type
series d
Description
Eikon has successfully raised $350.7 million in a Series D funding round, which will be used to accelerate the development of its cancer therapies. The company has raised over $1.1 billion since its inception in 2019 and plans to expand its clinical studies globally.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech